In their retrospective analysis on 2028 patients with CLL, Tsimberidou and colleagues reported that elevated levels of β2-microglobulin and LDH, but not the presence of cytogenetic aberrations, were independent factors predicting for the development of second cancers [180]. This evidence concerns the gene HLA-G and B-cell chronic lymphocytic leukemia.